Volume 2 Issue 5

Clinical Image

Choledochoduodenal Fistula in a Young Patient of Peptic Ulcer Disease

Authors: Gyanendu Kumar

Type: Clinical Image   

Research Article

Anus Diseases in Proctology Consultation in the Yaounde University Teaching Hospital (Cameroon): Male Predominance, Taboo and Neglected Diseases

Authors: Ankouane F, Kowo M, Biwolé Sida M, Tzeuton C and Ndjitoyap Ndam EC

Type: Research Article   

Research Article

A Risk Matrix Model for the Prediction of Intestinal Tuberculosis and Differentiation from Crohn’S Disease

Authors: Larsson G, Shenoy KT, Ramasubramanian R, Thayumanavan L, Balakumaran LK, Cvancarova M, Bjune GA and Moum BA

Type: Research Article   

Research Article

The Role of Oral Endoscope during Laparoscopic Intragastric Surgery of Gastric Submucosal Tumor

Authors: Tagaya N, Hakozaki Y, Yamaguchi N, Shimada M, Oya M, Matsunaga Y, Tatsuoka T, Kubota Y, Hirano K, Suzuki A, Saito K, Yamagata Y, Koketsu S, Okuyama T, Sugamata Y, Sameshima S and Oya M

Type: Research Article   

Review Article

Ulcerative Colitis Associated with Cholangiocellular Carcinoma: A Case Report and Literature Review

Authors: Fang Y, Lei L, Shen X, Wang J and Sheng R

Type: Review Article   

Special Article - Peptic Ulcer Disease

Peptic Ulcer Disease

Authors: Lauret ME, Rodriguez-Peláez M, Pérez I and Rodrigo L

Type: Special Article - Peptic Ulcer Disease   

Published Manuscripts

Impact Factor: 2.8


 About the Journal  

Austin Journal of Gastroenterology is an open access, peer reviewed, scholarly journal dedicated to publish articles related to original and latest advancement of in the field of Gastroenterology.

The aim of this journal is to provide a platform for research scholars and academicians around the globe to promote, share, and discuss various new issues and developments in different fields of

Featured Article

Safety Profile of Anti-TNF Agents in Polish Pediatric Patients with Crohn’s Disease

Abstract In recent years, monoclonal antibodies against TNF-alpha, infliximab (IFX) and Adalimumab, have been gaining increasing popularity in Crohn’s disease (CD) management.

© 2014 Austin Publications LLC